Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Aug 9, 2022

50715_rns_2022-08-09_fd801725-6099-43b7-a61a-ce03ba9440c4.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

9 August 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of dealings Purchase/ Sale Totalnumber ofsharesinvolved Total amountpaid / received Highest (H)prices paid/ received Lowest (L)prices paid/ received
China InternationalCapital CorporationLimited 8 August2022 Other typesof securities(e.g. equityswaps) Closing / flattening /unwinding of proprietarypositions arising fromunsolicited client-drivendealings. I confirm this wasdone no later than the close ofthe morning trading sessionon the trading day followingthe orginating client-drivendealing Sale 136,000 $3,508,704.8000 $25.7993 $25.7993

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Other typesof securities(e.g. equityswaps) Closing / flattening /unwinding of proprietarypositions arising fromunsolicited client-drivendealings. I confirm this wasdone no later than the close ofthe morning trading sessionon the trading day followingthe orginating client-drivendealing Purchase 136,000 $3,508,704.8000 $25.7993 $25.7993

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.